My research involves mixed methods evaluations (including costing) and implementation research on NCDs in humanitarian and LMIC settings. Current projects involve exploration of innovative models of care (integrated care, peer support) for hypertension and diabetes in Lebanon with the Partnership for Change group, involving ICRC, DRC and Novo Nordisk, and leading the qualitative component of the HumAn1 study, comparing human with analogue insulins in Bangladesh and Tanzania. Previously, I worked with MSF on evaluating their NCD services in DRC and Jordan and their introduction of a cardiovascular secondary prevention polypill in clinics in north Lebanon. I was also involved in a project documenting humanitarian actors' adaptations to NCD care during the Covid-19 pandemic. I am workstream co-lead for the International Alliance for Diabetes Action (IADA). I am passionate about working with humanitarian organisations to develop simplified, accessible and cost effective models of NCD care in unstable or resource-constrained environments, improving access to affordable medicines and strengthening monitoring, research and evaluation methods. I am especially interested in developing evaluation methods for complex interventions in insecure and dynamic humanitarian settings.